Please login to the form below
MSD’s Keytruda to be made available in England for advanced cervical cancer patients
Around 2,600 people are diagnosed with cervical cancer each year in England
Boehringer Ingelheim and Covant to collaborate on cancer immunotherapies
The deal to develop a small-molecule inhibitor could be worth over $480m
Eli Lilly increases investment to almost $1bn for new Irish manufacturing facility
The biologics manufacturing site is expected to create more than 300 highly skilled jobs
Regeneron and Sonoma Biotherapeutics partner on autoimmune disease therapies
Sonoma will receive $75m upfront and will be eligible for a $45m milestone payment
PMGroup announces launch of new recruitment platform PharmaRole
The platform makes it easy to find and apply for jobs in the pharmaceutical and life sciences industry
Merck reports positive results for Keytruda plus chemotherapy in endometrial cancer
It is estimated there will be around 66,000 new cases of uterine cancer in the US this year
BioNTech reveals plans to spend about €1bn more on research and development this year
The company has already started clinical trials assessing four new infectious disease vaccines
AstraZeneca’s mild combination asthma reliever approved in UK
Over two and a half million adults with mild cases of asthma could be eligible for the treatment
FDA proposes improvements for oncology clinical trials supporting accelerated approval
The draft guidance discusses the advantage of randomised clinical trials over single-arm studies
Q&A: Claire Gillis
PME interviews VMLY&Rx's CEO
-
Q&A: Sarah GordonPME interviews Virgo Health's head of health
-
Q&A: Amar UrhekarPME interviews Ashfield Health's Global President
-
NHS England announces rare genetic disorder fast-tracking servicePatients with inherited white matter disorders will benefit from earlier diagnosis and specialist care
-
NICE sees ‘promise’ in four UTI tests that could help in fight against AMRThe tests can identify the presence of bacteria in a urine sample in less than 40 minutes
-
AstraZeneca/MSD’s Lynparza combination approved in UK for prostate cancerMore than 52,000 men are diagnosed with prostate cancer every year in the UK alone
-
WHO report highlights impact of COVID-19 pandemic on non-communicable diseasesThese diseases were responsible for an estimated 40 million of all deaths globally in 2019
-
Novo Nordisk and Dewpoint partner on insulin resistance drug candidatesInsulin resistance affects around 15.5% to 46.5% of the world’s population
-
AbbVie’s Parkinson’s disease therapy application rejected by FDAThe regulator has requested more information on the pump used to administer ABBV-95
-
MHRA to introduce new UK clinical trials frameworkThe changes will aim to make it easier to gain approval and to run clinical trials in the UK
Latest appointments
-
Inizio appoints Stefanie Christmas as global head of DE&IChristmas joins from Vynamic, where she founded the firm’s DE&I efforts in 2016
-
The Considered appoints Bam Zahraie as chief experience officerZahraie was previously global innovation lead and associate managing director at Havas Health & You
-
Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences divisionArnhofer was most recently senior vice president of customer strategy at BioNTech SE
-
Wave Healthcare Communications appoints Gareth Tucker as commercial directorTucker was previously chief executive officer of Obsidian Healthcare Group
-
Ketchum appoints Conor Nash as global chief financial officer and chief operating officerNash was most recently Ogilvy’s chief operating officer in North America
Subscribe to our email news alerts
-
Pharmacovigilance Manager
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
- Associate Director - Global Healthcare Consulting
- £100,000 - £115,000 yearly
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- £90,000 - £120,000 yearly
-
Senior Medical Writer
- Highly competitive salary
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- MHRA to introduce new UK clinical trials framework
- FDA proposes improvements for oncology clinical trials supporting accelerated approval
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- Takeda presents positive phase 2b results for TAK-279 in plaque psoriasis
- MSD’s Keytruda to be made available in England for advanced cervical cancer patients
- Boehringer Ingelheim and Covant to collaborate on cancer immunotherapies
- Eli Lilly increases investment to almost $1bn for new Irish manufacturing facility
- Regeneron and Sonoma Biotherapeutics partner on autoimmune disease therapies
- Improving cardiovascular disease care and awareness
- PMGroup announces launch of new recruitment platform PharmaRole
- Locus Biosciences announces first patient treated in urinary tract infection trial
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- The state of pharma customer experience
- Merck reports positive results for Keytruda plus chemotherapy in endometrial cancer
- MHRA to introduce new UK clinical trials framework
- Takeda presents positive phase 2b results for TAK-279 in plaque psoriasis
Latest intelligence
- Improving cardiovascular disease care and awareness
- Scott Curley talks to PME about the risks of CVD and the importance of getting the right treatment at the right time...
- Virtual Patient Engagement Program: A Customer Story
- Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......
- Humancomms for humancare?
- Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...
